Evidence map›Paper›PMID 39247433›Full record

ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2024

Role of Triglyceride-Glucose Index in Type 2 Diabetes Mellitus and Its Complications.

Ying Pan, Mengjie Zhao, Tiantian Song, Jia Tang, Ming Kuang, Hongying Liu, Shao Zhong

Abstract readReview
In one paragraph

Review in Diabetes, metabolic syndrome and obesity : targets and therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ying PanDepartment of General Practice, Kunshan Hospital Affiliated to Jiangsu University, Kunshan, Jiangsu, People's Republic of China.ORCID 0000-0001-9935-6194
Mengjie ZhaoDepartment of General Practice, Kunshan Hospital Affiliated to Jiangsu University, Kunshan, Jiangsu, People's Republic of China.ORCID 0009-0004-7081-4664
Tiantian SongHangzhou Kang Ming Information Technology Co., Ltd, Hangzhou, Zhejiang, People's Republic of China.ORCID 0009-0006-3710-5131
Jia TangHangzhou Kang Ming Information Technology Co., Ltd, Hangzhou, Zhejiang, People's Republic of China.
Ming KuangHangzhou Kang Ming Information Technology Co., Ltd, Hangzhou, Zhejiang, People's Republic of China.
Hongying Liu *Hangzhou Kang Ming Information Technology Co., Ltd, Hangzhou, Zhejiang, People's Republic of China.ORCID 0000-0002-8573-8535
Shao Zhong *Department of Endocrinology, Gusu School, Nanjing Medical University, The First People's Hospital of Kunshan, Kunshan, Jiangsu, People's Republic of China.ORCID 0000-0002-9054-6554

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin resistance (IR) is the major mechanism in the pathogenesis of type 2 diabetes mellitus (T2DM). Early identification of IR is of great significance for preventing the onset of T2DM and delaying the progression of the disease. Previous studies have shown that triglyceride-glucose (TyG) index can be used as an effective surrogate marker for IR. There is a significant correlation between TyG index and T2DM and its common complications. In addition, the predictive efficacy of TyG index is better than that of other IR surrogate indicators. TyG index may not only become an important marker to identify people at high risk of T2DM and its complications, but is also expected to become a strong predictor of the prognosis of these diseases. However, there are still some challenges in the widespread application of TyG index in clinical practice. In the future, more high-quality studies are needed to clarify the assessment methods of TyG index for the prognosis of T2DM and its complications. Further investigations of the relationship between TyG index and T2DM and its complications will be expected to provide new ideas and methods for the prevention and treatment of T2DM and its complications.

Indexed as

complicationinsulin resistancetriglyceride-glucose indextype 2 diabetes mellitus

Identifiers

PMID39247433
PMCPMC11380872

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.